On your Mercks: rich nations rushing to repeat mistakes with Covid pill

As with the global vaccine situation, some wealthy and middle-income nations have raced to the front of the queue

12 October 2021 - 20:57 By James Paton

Moves by a small group of countries to acquire supplies of Merck’s promising Covid pill before it’s even approved are raising concerns that some poorer nations could be left behind in a repeat of the slow and inequitable rollout of vaccines.

A global initiative to deploy Covid therapies like Merck’s molnupiravir is at risk of running into the same problems the Covax effort faced and has no clear mechanism to negotiate contracts and supply countries, according to an independent report commissioned by the World Health Organisation...

This article is free to read if you register or sign in.

If you have already registered or subscribed, please sign in to continue.

Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.